| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $34,353,835 | 9 | 100 |
Sells | $0 | 0 | 0 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9 | $34.35M | 0 | $0 | $34.35M |
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Over the last 12 months, insiders at Benitec Biopharma Inc. have bought $34.35M and sold $0 worth of Benitec Biopharma Inc. stock.
On average, over the past 5 years, insiders at Benitec Biopharma Inc. have bought $11.9M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SUVRETTA CAPITAL MANAGEMENT, LLC () — $34.35M.
The last purchase of 77,387 shares for transaction amount of $1.04M was made by SUVRETTA CAPITAL MANAGEMENT, LLC () on 2025‑12‑29.
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC | 77,387 0.3025% | $13.44 | $1.04M | -10.98% | |||
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | 16,836 0.0641% | $13.10 | $220,552 | -8.21% | |||
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | 50,000 0.1982% | $12.85 | $642,500 | -6.75% | |||
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC | 19,542 0.0728% | $12.08 | $236,067 | -1.78% | |||
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | 16,384 0.0623% | $11.48 | $188,088 | +6.43% | |||
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC | 10,215 0.0384% | $11.24 | $114,817 | +6.59% | |||
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC | 1.48M 4.657% | $13.50 | $20M | +0.78% | |||
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | 16,497 0.0638% | $12.83 | $211,736 | +2.00% | |||
| 2025-03-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | 900,000 3.561% | $13.00 | $11.7M | -5.10% | |||
| 2024-12-24 | SUVRETTA CAPITAL MANAGEMENT, LLC | 20,018 0.0838% | $11.25 | $225,203 | +13.69% | |||
| 2024-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | 27,502 0.1165% | $10.98 | $301,972 | +17.13% | |||
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC | 42,000 0.1737% | $9.60 | $403,200 | +31.40% | |||
| 2024-11-20 | SUVRETTA CAPITAL MANAGEMENT, LLC | 27,436 0.113% | $10.22 | $280,396 | +23.08% | |||
| 2024-11-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | 14,000 0.0584% | $9.73 | $136,220 | +32.49% | |||
| 2023-08-11 | BUCHI J KEVIN | director | 51,813 <0.0001% | $0.00 | $5 | +28.83% | ||
| 2023-08-11 | Boston Megan | Executive Director | 25,907 <0.0001% | $0.00 | $3 | +28.83% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9700195 36.9573% | $121.06M | 14 | 0 | +23.56% | |
| BUCHI J KEVIN | director | 52097 0.1985% | $650,170.56 | 1 | 0 | +28.83% |
| Boston Megan | Executive Director | 25907 0.0987% | $323,319.36 | 1 | 0 | +28.83% |
$26,880,005 | 99 | 5.38% | $326.4M | |
$5,960,789 | 91 | -7.17% | $352.88M | |
$69,137,799 | 70 | 25.27% | $330.63M | |
$87,639,490 | 62 | 18.37% | $312.24M | |
$63,049,419 | 31 | 2.87% | $344.2M | |
$79,019,806 | 27 | 7.24% | $315.83M | |
$54,828,550 | 26 | -13.88% | $360.9M | |
$1,842,003 | 22 | -0.74% | $286M | |
$22,365,077 | 19 | -27.47% | $340.37M | |
$1,447,973 | 17 | 13.95% | $336.3M | |
$65,355,913 | 13 | -3.42% | $360.7M | |
$13,043,783 | 8 | 732.82% | $306.12M | |
Benitec Biopharma Inc. (BNTC) | $1,346,998 | 7 | 25.06% | $327.56M |
$17,675,244 | 7 | 92.20% | $323.51M | |
$272,982 | 6 | -28.53% | $298.11M | |
$88,549,962 | 5 | -16.91% | $371.75M | |
$4,888,000 | 3 | -20.50% | $344.46M | |
$37,067 | 3 | -89.81% | $284.6M | |
$136,410 | 2 | -13.40% | $321.88M |
| Increased Positions | 33 | +68.75% | 760,998 | +3.36% |
| Decreased Positions | 18 | -37.5% | 283,787 | -1.25% |
| New Positions | 7 | New | 13,898 | New |
| Sold Out Positions | 7 | Sold Out | 123,060 | Sold Out |
| Total Postitions | 63 | +31.25% | 23M | +2.1% |
| Suvretta Capital Management, Llc | $124,296.00 | 29.05% | 9.88M | 0 | 0% | 2025-09-30 |
| Janus Henderson Group Plc | $36,644.00 | 8.56% | 2.91M | +8,894 | +0.31% | 2025-09-30 |
| Franklin Resources Inc | $32,591.00 | 7.62% | 2.59M | -111,810 | -4.14% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $24,824.00 | 5.8% | 1.97M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $12,486.00 | 2.92% | 992,114 | +22,948 | +2.37% | 2025-09-30 |
| Blackrock, Inc. | $11,899.00 | 2.78% | 945,515 | +226,825 | +31.56% | 2025-09-30 |
| Nantahala Capital Management, Llc | $10,547.00 | 2.47% | 838,095 | 0 | 0% | 2025-09-30 |
| Infinitum Asset Management, Llc | $6,293.00 | 1.47% | 500,000 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $5,519.00 | 1.29% | 438,505 | +23,294 | +5.61% | 2025-09-30 |
| Silverarc Capital Management, Llc | $3,477.00 | 0.81% | 276,267 | +23,033 | +9.1% | 2025-09-30 |